Insider trading

Period: 120 months Stock: CVS Minimum amount: $100K × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

102 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

102 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

102 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

102 decisions over 120 months Remove this filter
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
102 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
102 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

102 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
21 May 2026
ROBBINS LARRY Director · indirect
Sold at will
$34.62M 370,462 at 93.45
7.1%
Not planned
20 May 2026
ROBBINS LARRY Director · indirect
Sold at will 4×
$95.51M 1,018,000 at 93.82
16.4%
Not planned
19 May 2026
ROBBINS LARRY Director · indirect
Sold at will 2×
$187.34M 1,983,538 at 94.45
24.2%
Not planned
8 May 2026
Mandadi Tilak EVP, Chief Exp & Tech Officer
Sold at will
$6.23M 69,551 at 89.58
87.3%
Sold half or more
20 Aug 2025
Finucane Anne A. Director · indirect
Sold at will
$532.65K 7,500 at 71.02
25.3%
Not planned
5 Jun 2025
SANSONE GUY P Director
Bought
$100.01K 1,570 at 63.70
15.0%
First buy on file
6 May 2025
ROBBINS LARRY Director · indirect
Sold at will
$10.00M 150,000 at 66.67
1.8%
Not planned
5 May 2025
ROBBINS LARRY Director · indirect
Sold at will 2×
$89.25M 1,323,932 at 67.41
13.7%
Not planned
2 May 2025
ROBBINS LARRY Director · indirect
Sold at will 3×
$154.44M 2,276,068 at 67.86
19.1%
Not planned
5 Mar 2025
Clark James David SVP, Cont & Chief Acct Officer
Sold at will
$498.49K 7,513 at 66.35
47.2%
Not planned
18 Feb 2025
Bought
$2.00M 30,000 at 66.70
321%
Largest buy in 3 yrs
2 May 2024
Bought
$500.29K 9,181 at 54.49
×52
First buy on file
16 Feb 2024
Shah Prem S EVP and Pres-Pharm, Consumer W
Sold at will
$2.27M 29,473 at 76.95
42.6%
Not planned
3 Nov 2023
LUDWIG EDWARD J Director
Bought
$140.93K 2,000 at 70.47
10.7%
3 Aug 2023
Clark James David SVP, Cont & Chief Acct Officer
Sold at will 2×
$1.93M 25,759 at 74.92
84.6%
Sold half or more
3 May 2023
Lynch Karen S President and CEO
Bought
$976.57K 14,000 at 69.75
3.4%
First buy on file
15 Dec 2022
Moriarty Thomas M EVP & General Counsel
Sold, plan not stated 2×
$13.52M 137,466 at 98.36
18.4%
4 Aug 2022
Lotvin Alan EVP&President-PharmacyServices
Sold, plan not stated
$2.34M 22,541 at 104.00
17.1%
3 Aug 2022
Lotvin Alan EVP&President-PharmacyServices
Sold, plan not stated 2×
$11.85M 120,899 at 98.00
52.5%
Sold half or more
3 Aug 2022
Finke Daniel P EVP/Pres, Health Care Benefits
Sold, plan not stated
$954.60K 9,546 at 100.00
22.9%
28 Jun 2022
Moriarty Thomas M EVP & General Counsel
Sold, plan not stated 3×
$13.17M 138,654 at 95.00
18.1%
8 Apr 2022
Shah Prem S EVP and Co-President of Retail
Sold, plan not stated 5×
$1.78M 16,954 at 105.00
28.1%
5 Apr 2022
Finke Daniel P EVP/Pres, Health Care Benefits
Sold, plan not stated
$594.10K 5,941 at 100.00
15.6%
4 Apr 2022
Finke Daniel P EVP/Pres, Health Care Benefits
Sold, plan not stated 3×
$5.54M 55,359 at 100.13
59.2%
Sold half or more
30 Mar 2022
Shah Prem S EVP and Co-President of Retail
Sold, plan not stated
$559.73K 5,346 at 104.70
8.3%
17 Mar 2022
Shah Prem S EVP and Co-President of Retail
Sold, plan not stated 2×
$493.15K 4,624 at 106.65
7.3%
15 Mar 2022
Moriarty Thomas M EVP & General Counsel
Sold, plan not stated
$5.39M 51,361 at 105.00
5.8%
10 Feb 2022
LUDWIG EDWARD J Director
Bought
$105.90K 1,000 at 105.90
5.8%
3 Feb 2022
Brennan Troyen A EVP and Chief Medical Officer
Sold, plan not stated
$5.27M 47,937 at 110.00
25.7%
1 Feb 2022
Lotvin Alan EVP&President-PharmacyServices
Sold, plan not stated
$2.28M 21,386 at 106.50
25.9%
28 Jan 2022
Clark James David SVP, Cont & Chief Acct Officer
Sold, plan not stated
$660.43K 6,059 at 109.00
25.7%
27 Jan 2022
Roberts Jonathan C EVP & Chief Operating Officer
Sold, plan not stated
$7.36M 68,482 at 107.50
39.0%
3 Nov 2021
Roberts Jonathan C EVP & Chief Operating Officer
Sold, plan not stated
$10.34M 108,870 at 95.00
50.4%
Sold half or more
1 Nov 2021
Brennan Troyen A EVP and Chief Medical Officer
Sold, plan not stated
$2.53M 28,159 at 90.00
16.9%
26 Oct 2021
Brennan Troyen A EVP and Chief Medical Officer
Sold, plan not stated 2×
$7.28M 82,757 at 88.00
37.4%
2 Sep 2021
Brennan Troyen A EVP and Chief Medical Officer
Sold, plan not stated
$228.38K 2,625 at 87.00
1.8%
5 Aug 2021
LUDWIG EDWARD J Director
Bought
$238.64K 3,000 at 79.55
20.9%
Largest buy in 3 yrs
28 Jun 2021
Lotvin Alan EVP&President-PharmacyServices
Sold, plan not stated
$232.69K 2,781 at 83.67
4.4%
15 Jun 2021
Brennan Troyen A EVP and Chief Medical Officer
Sold, plan not stated
$5.81M 67,552 at 86.00
32.1%
7 Jun 2021
Finke Daniel P EVP/Pres, Health Care Benefits
Sold, plan not stated
$3.26M 37,594 at 86.60
61.7%
Sold half or more
10 May 2021
Moriarty Thomas M EVP & General Counsel
Sold, plan not stated
$9.41M 109,469 at 86.00
100%
Sold half or more
7 May 2021
Brennan Troyen A EVP and Chief Medical Officer
Sold, plan not stated
$796.07K 9,477 at 84.00
6.1%
4 May 2021
Boratto Eva C EVP & CFO
Sold, plan not stated
$392.40K 4,905 at 80.00
4.1%
21 Apr 2021
Moriarty Thomas M EVP & General Counsel
Sold, plan not stated 2×
$7.96M 103,423 at 77.00
100%
Sold half or more
31 Mar 2021
Clark James David SVP, Cont & Chief Acct Officer
Sold, plan not stated
$406.60K 5,350 at 76.00
42.5%
29 Mar 2021
Moriarty Thomas M EVP & General Counsel
Sold, plan not stated
$4.79M 62,943 at 76.15
100%
Sold half or more
26 Mar 2021
MERLO LARRY J Director
Sold, plan not stated
$20.23M 270,650 at 74.73
34.1%
26 Mar 2021
Roberts Jonathan C EVP & Chief Operating Officer
Sold, plan not stated
$5.47M 73,433 at 74.49
99.1%
Sold half or more
19 Mar 2021
Moriarty Thomas M EVP & General Counsel · indirect
Sold, plan not stated
$3.65M 49,211 at 74.15
73.0%
Sold half or more
16 Mar 2021
Boratto Eva C EVP & CFO
Sold, plan not stated
$1.41M 18,882 at 74.68
21.0%
Showing 1–50 of 102. Page 1 of 3 Older →